Showing results (1691-1700 of 1,763) with videos related to

Sort By:
Pageof 177
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 5, 2024
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in AdultsChristopher Hahn, Adrian Budhram, Katayoun Alikhani, et al.
Journal of the American Academy of Dermatology|April 5, 2011
Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings reportC William Hanke, Rod J Rohrich, Mariano Busso, et al.
Journal of the American Academy of Dermatology|April 5, 2011
Facial Soft-Tissue Fillers conference: Assessing the State of the ScienceC William Hanke, Rod J Rohrich, Mariano Busso, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|January 7, 2023
Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort studyAnna Goulding, Fiona McQuaid, Laura Lindsay, et al.
Molecular Cancer Therapeutics|November 21, 2024
Pancreatic CAF-Derived Autotaxin Drives Autocrine CTGF Expression to Modulate Protumorigenic SignalingFanny Volat, Ragini Medhi, Lauren Z Maggs, et al.
JAMA Network Open|September 29, 2020
Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple SclerosisShawna Abel, Irene Vavasour, Lisa Eunyoung Lee, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2012
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trialAndrew R Pettitt, Richard Jackson, Stacey Carruthers, et al.
The European Respiratory Journal|April 20, 2023
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosisKaterina Koether, Valérie Besnard, Hilary Sandig, et al.
Pageof 177